An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these accounts directly for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where groups with numerous of members share comparison photos, injection guides and assertions of rapid British shipping. Vendors market the drug there before redirecting customers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.
Some professionals stated the demand for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Platform Response and Material Removal
According to the social media company, the service has taken down problematic material and banned associated keywords and query recommendations. The organization stated it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.
Online Trading Activities
Research also discovered communities with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with images of slimming results, glowing reviews and step-by-step instructions for mixing or administering at home.
Within minutes of entering one group, a seller shared WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.
Product Details and Pricing
Within these groups, posts display black plastic packages with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how much time a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has previously seen individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to potentially serious medical dangers”.
